Nestlé Health Science buys $250m gastro diagnostics firm
The new Health Science division Nestlé created last September has made its second acquisition by buying $250m a year US gastroenterology and oncology diagnostic specialist, Prometheus Laboratories Inc., for an undisclosed sum.